ISP-20-3 Treatment strategy for recurrent clear cell carcinomas of the ovary(Group 20 Oncology 11,IS Poster,International Session)
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本産科婦人科学会の論文
- 2013-02-01
著者
-
FURUYA Kenichi
National Defense Medical Collage
-
MAKIMURA Noriko
National Defense Medical Collage
-
Sasa Hidenori
National Defense Medical College
-
SUZUKI Ayako
National Agricultural Research Center for Hokkaido Region
-
Hirata Junko
National Defense Medical College, Department of Obstetrics and Gynecology
-
Takano Masashi
National Defense Medical College Department Of Obstetrics And Gynecology
-
Soyama Hiroaki
National Defense Medical College
-
Goto Tomoko
National Defense Medical College
-
Aoyama Tadashi
National Defense Medical College
-
Miyamoto Morikazu
National Defense Medical College
-
Kato Masafumi
National Defense Medical College
-
Sasaki Naoki
National Defense Medical College
-
Hirata Junko
National Defense Medical College
-
Takano Masashi
National Defense Medical College
関連論文
- IS-36 Two cases of complete remission of metastatic and relapsed uterine cervical carcinoma using weekly administration of bevacizumab and paclitaxel/carboplatin(Group4 Oncology2,International Session)
- IS-33 Experience of combination therapy with Bevacizumab for recurrent/refractory clear cell carcinoma of the ovary(Group4 Oncology2,International Session)
- P1-IS-35 Clear cell carcinoma of the ovary : retrospective analysis of Japan Clear Cell Carcinoma Study
- Clinical significance of first-line chemotherapy and complete surgical staging for clear cell adenocarcinoma of the ovary(Oncology 3)
- PDZK1 is a potential target for 1q21-q22 amplification frequently detected in drug resistant ovarian cancer(Oncology 1)
- 4-13.CGH and cDNA micoarray analysis of drug resistance in gynecologic malignancy(Session 6 Oncology 6)
- Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin : retrospective analysis
- IS-67 Immunological Study on Intra-peritoneal Lymphocyte Subpopulation in Patient with Endometriosis
- P3-IS-10 Functional analysis of FOXO1 in endometrial cancer cells(Group86 Oncology2,International Session)
- P1-IS-5 Clinical significance of immunocytochemistry for PIK3CA as a carcinogenesis-related marker on liquid-based cytology in cervical intraepithelial neoplasia
- Estimation of Measurement Characteristics of Ultrasound Fetal Heart Rate Monitor
- P3-IS-33 Evaluation of cold-knife conization for cervical lesions on prognosis and complications(Group88 Oncology4,International Session)
- Genetic analysis of variation in sugar chain composition at the C-22 position of group A saponins in soybean, Glycine max (L.) Merrill
- ISO-7 p16INK4a expression in cytology of ascites and response to chemotherapy in advanced ovarian cancer(Group1 Oncology,International Session: Oral Presentation)
- Indispensability of UGT1A1^*6 genotyping in Japanese cancer patients treated with irinotecan
- IS-71 Conservative management of advanced interstitial pregnancy with uterine artery embolization and systemic methotrexate treatment: a case report(Group9 Perinatology2,International Session)
- P-IS-63 Relationship between adipocytokine and menstrual dysfunction by weight change(Reproduction 3,Group 104,International Session)
- 2-12.Clinical prospective study on post-surgical bladder dysfunction at radical hysterectomy in aspect of histological analysis of pelvic nerve innervations.(Session 3 Oncology 3)
- IS-29 The role of FOXO1 in the mechanism of cytotoxicity and drug-resistance induced by paclitaxel in ovarian cancer(Group4 Oncology2,International Session)
- IS-25 GTPase-activating protein regulates growth of chorionic villi in first trimester of pregnancy
- ISO-6 Retrospective analyses on prognosis of high grade endometrial cancer : A comparison of serous type and clear cell type to Grade 3 endometrioid type(Group1 Oncology,International Session : Oral Presentation)
- IS-15 Patients with stage IIIc ovarian clear cell carcinoma upstaged by lymph node metastasis have similar survival to other stage III clear cell carcinoma patients(Group2 Oncology2,International Session)
- Weekly administration of temsirolimus for heavily pretreated patients with clear cell carcinoma of the ovary : a report of six cases
- ISP-20-3 Treatment strategy for recurrent clear cell carcinomas of the ovary(Group 20 Oncology 11,IS Poster,International Session)
- ISP-7-8 A trial of low-dose dienogest treatment for a patient with adenomyosis(Group 7 Reproduction 1,IS Poster,International Session)
- ISP-3-4 A role of neoadjuvant chemotherapy (NAC) for advanced endometrial carcinoma (EC) in comparison with ovarian carcinoma (OC)(Group 3 Oncology 3,IS Poster,International Session)
- ISP-18-4 Low-dose dienogest for long-term treatment of adenomyosis in comparison with low-dose danazol(Group 18 Reproduction 1,IS Poster,International Session)